Search details
1.
NRG-GY012: Randomized phase 2 study comparing olaparib, cediranib, and the combination of cediranib/olaparib in women with recurrent, persistent, or metastatic endometrial cancer.
Cancer
; 130(8): 1234-1245, 2024 Apr 15.
Article
in English
| MEDLINE | ID: mdl-38127487
2.
Phase II trial of pembrolizumab and epacadostat in recurrent clear cell carcinoma of the ovary: An NRG oncology study GY016.
Gynecol Oncol
; 186: 61-68, 2024 Apr 10.
Article
in English
| MEDLINE | ID: mdl-38603953
3.
Temporal Trends in the Remaining Lifetime Risk of Cardiovascular Disease Among Middle-Aged Adults Across 6 Decades: The Framingham Study.
Circulation
; 145(17): 1324-1338, 2022 04 26.
Article
in English
| MEDLINE | ID: mdl-35430874
4.
Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer.
N Engl J Med
; 381(20): 1929-1939, 2019 11 14.
Article
in English
| MEDLINE | ID: mdl-31722153
5.
Prognostic significance of ethnicity and age in advanced stage epithelial ovarian cancer: An NRG oncology/gynecologic oncology group study.
Gynecol Oncol
; 164(2): 398-405, 2022 02.
Article
in English
| MEDLINE | ID: mdl-34857397
6.
Correlation of imaging and plasma based biomarkers to predict response to bevacizumab in epithelial ovarian cancer (EOC).
Gynecol Oncol
; 161(2): 382-388, 2021 05.
Article
in English
| MEDLINE | ID: mdl-33712274
7.
Standardization of lower extremity quantitative lymphedema measurements and associated patient-reported outcomes in gynecologic cancers.
Gynecol Oncol
; 160(2): 625-632, 2021 02.
Article
in English
| MEDLINE | ID: mdl-33158510
8.
The addition of paclitaxel to doxorubicin and cisplatin and volume-directed radiation does not improve overall survival (OS) or long-term recurrence-free survival (RFS) in advanced endometrial cancer (EC): A randomized phase III NRG/Gynecologic Oncology Group (GOG) study.
Gynecol Oncol
; 154(1): 13-21, 2019 07.
Article
in English
| MEDLINE | ID: mdl-31053405
9.
Measures for evaluation of prognostic improvement under multivariate normality for nested and nonnested models.
Stat Med
; 38(20): 3817-3831, 2019 09 10.
Article
in English
| MEDLINE | ID: mdl-31211443
10.
Recontact practices of cancer genetic counselors and an exploration of professional, legal, and ethical duty.
J Genet Couns
; 28(4): 836-846, 2019 08.
Article
in English
| MEDLINE | ID: mdl-31058402
11.
Association of Exhaled Carbon Monoxide With Stroke Incidence and Subclinical Vascular Brain Injury: Framingham Heart Study.
Stroke
; 47(2): 383-9, 2016 Feb.
Article
in English
| MEDLINE | ID: mdl-26696648
12.
Association of Ideal Cardiovascular Health With Vascular Brain Injury and Incident Dementia.
Stroke
; 47(5): 1201-6, 2016 05.
Article
in English
| MEDLINE | ID: mdl-27073239
13.
Ideal cardiovascular health: associations with biomarkers and subclinical disease and impact on incidence of cardiovascular disease in the Framingham Offspring Study.
Circulation
; 130(19): 1676-83, 2014 Nov 04.
Article
in English
| MEDLINE | ID: mdl-25274000
14.
Association of exhaled carbon monoxide with subclinical cardiovascular disease and their conjoint impact on the incidence of cardiovascular outcomes.
Eur Heart J
; 35(42): 2980-7, 2014 Nov 07.
Article
in English
| MEDLINE | ID: mdl-24574370
15.
Radiation Therapy With or Without Cisplatin for Local Recurrences of Endometrial Cancer: Results From an NRG Oncology/GOG Prospective Randomized Multicenter Clinical Trial.
J Clin Oncol
; : JCO2301279, 2024 Apr 25.
Article
in English
| MEDLINE | ID: mdl-38662968
16.
Missing repeated measures data in clinical trials.
Neurooncol Pract
; 9(1): 35-42, 2022 Feb.
Article
in English
| MEDLINE | ID: mdl-35096402
17.
Lifetime Risk of Heart Failure Among Participants in the Framingham Study.
J Am Coll Cardiol
; 79(3): 250-263, 2022 01 25.
Article
in English
| MEDLINE | ID: mdl-35057911
18.
Clinical course after a first episode of heart failure: insights from the Framingham Heart Study.
Eur J Heart Fail
; 22(10): 1768-1776, 2020 10.
Article
in English
| MEDLINE | ID: mdl-32462760
19.
Sequential Ipilimumab After Chemoradiotherapy in Curative-Intent Treatment of Patients With Node-Positive Cervical Cancer.
JAMA Oncol
; 6(1): 92-99, 2020 Jan 01.
Article
in English
| MEDLINE | ID: mdl-31774464
20.
Immune Activation in Patients with Locally Advanced Cervical Cancer Treated with Ipilimumab Following Definitive Chemoradiation (GOG-9929).
Clin Cancer Res
; 26(21): 5621-5630, 2020 11 01.
Article
in English
| MEDLINE | ID: mdl-32816895